Group One Trading, L.P. Coherus Bio Sciences, Inc. Transaction History

Group One Trading, L.P.

  • $2.68 Billion
  • Q2 2025

A detailed history of Group One Trading, L.P. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 90,431 shares of CHRS stock, worth $159,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,431
Previous 124,915 27.61%
Holding current value
$159,158
Previous $101,000 34.65%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$0.72 - $1.12 $24,828 - $38,622
-34,484 Reduced 27.61%
90,431 $66,000
Q1 2025

May 14, 2025
BUY
$0.81 - $1.66 $101,181 - $207,358
124,915 New
124,915 $101,000
Q3 2024

Nov 14, 2024
SELL
$0.99 - $1.8 $23,314 - $42,390
-23,550 Reduced 15.5%
128,359 $133,000
Q2 2024

Aug 14, 2024
SELL
$1.58 - $2.51 $103,856 - $164,987
-65,732 Reduced 30.2%
151,909 $262,000
Q1 2024

May 10, 2024
SELL
$2.02 - $3.14 $250,108 - $388,782
-123,816 Reduced 36.26%
217,641 $520,000
Q4 2023

Feb 14, 2024
BUY
$1.59 - $3.85 $542,916 - $1.31 Million
341,457 New
341,457 $1.14 Million
Q2 2023

Aug 09, 2023
BUY
$3.79 - $8.3 $264,197 - $578,584
69,709 Added 1021.23%
76,535 $326,000
Q1 2023

May 12, 2023
SELL
$5.89 - $10.52 $67,511 - $120,580
-11,462 Reduced 62.67%
6,826 $46,000
Q4 2022

Feb 09, 2023
SELL
$5.69 - $10.07 $31,864 - $56,392
-5,600 Reduced 23.44%
18,288 $144,000
Q3 2022

Nov 09, 2022
BUY
$7.17 - $13.87 $160,464 - $310,410
22,380 Added 1484.08%
23,888 $230,000
Q2 2022

Aug 11, 2022
SELL
$5.86 - $13.23 $2,056 - $4,643
-351 Reduced 18.88%
1,508 $11,000
Q1 2022

May 12, 2022
SELL
$10.92 - $16.41 $101,719 - $152,859
-9,315 Reduced 83.36%
1,859 $24,000
Q4 2021

Feb 11, 2022
BUY
$15.81 - $18.99 $148,092 - $177,879
9,367 Added 518.37%
11,174 $178,000
Q3 2021

Nov 12, 2021
SELL
$12.68 - $17.79 $6,124 - $8,592
-483 Reduced 21.09%
1,807 $29,000
Q2 2021

Aug 10, 2021
SELL
$12.95 - $15.41 $3,936 - $4,684
-304 Reduced 11.72%
2,290 $32,000
Q1 2021

May 12, 2021
SELL
$14.42 - $21.39 $27,715 - $41,111
-1,922 Reduced 42.56%
2,594 $38,000
Q4 2020

Feb 10, 2021
SELL
$16.56 - $18.94 $225,066 - $257,413
-13,591 Reduced 75.06%
4,516 $78,000
Q3 2020

Nov 12, 2020
BUY
$17.41 - $19.89 $140,812 - $160,870
8,088 Added 80.73%
18,107 $332,000
Q2 2020

Aug 13, 2020
SELL
$14.43 - $19.16 $78,802 - $104,632
-5,461 Reduced 35.28%
10,019 $179,000
Q1 2020

May 13, 2020
BUY
$11.67 - $22.53 $17,224 - $33,254
1,476 Added 10.54%
15,480 $251,000
Q4 2019

Feb 10, 2020
SELL
$16.33 - $21.37 $124,924 - $163,480
-7,650 Reduced 35.33%
14,004 $252,000
Q3 2019

Nov 12, 2019
BUY
$16.3 - $23.37 $668 - $958
41 Added 0.19%
21,654 $439,000
Q2 2019

Aug 09, 2019
BUY
$13.1 - $22.1 $283,130 - $477,647
21,613 New
21,613 $478,000
Q1 2019

May 13, 2019
SELL
$8.38 - $15.5 $1,173 - $2,170
-140 Closed
0 $0
Q4 2018

Feb 06, 2019
BUY
$8.65 - $16.28 $1,211 - $2,279
140 New
140 $1,000
Q2 2018

Aug 14, 2018
SELL
$10.25 - $17.45 $122,231 - $208,091
-11,925 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$9.1 - $13.7 $38,820 - $58,444
-4,266 Reduced 26.35%
11,925 $132,000
Q4 2017

Feb 09, 2018
SELL
$8.35 - $14.4 $185,562 - $320,011
-22,223 Reduced 57.85%
16,191 $142,000
Q3 2017

Nov 15, 2017
BUY
$11.1 - $14.5 $349,905 - $457,083
31,523 Added 457.45%
38,414 $513,000
Q2 2017

Aug 14, 2017
BUY
N/A
6,891
6,891 $99,000

Others Institutions Holding CHRS

# of Institutions
120
Shares Held
58.2M
Call Options Held
89.3K
Put Options Held
31K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $137M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email